SXC Health Solutions announces five year renewal contract with Catalyst Rx



    - SXC to provide PBM claims processing and technology solutions -

    LOMBARD, IL, March 5 /CNW/ - SXC Health Solutions, Inc. ("SXC" or the
"Company") (NASDAQ:   SXCI, TSX: SXC), and Catalyst Rx, the pharmacy benefit
management subsidiary of HealthExtras, Inc., announced today that they have
entered into a five-year transaction processing contract renewal. Under terms
of the contract, SXC will continue to provide Catalyst Rx with RxCLAIM(R) for
on-line adjudication services of prescription drug claims, Medicare Part D
claims processing, and access to its suite of Web Services.
    "We are pleased to extend our relationship with Catalyst Rx and support
their continued growth in the Pharmacy Benefits Management (PBM) market," said
Gordon S. Glenn, Chairman and Chief Executive Officer, SXC Health Solutions,
Inc.
    "Our relationship with SXC has allowed Catalyst Rx to aggressively grow
our PBM business. SXC has been a strong technology and services partner, and
we look forward to continued success together," stated David T. Blair, Chief
Executive Officer, HealthExtras, Inc.

    About HealthExtras (www.healthextras.com)
    HealthExtras, Inc. is a full-service pharmacy management company. Its
clients include self-insured employers, including state and local governments,
third-party administrators, managed care organizations and individuals. The
Company's integrated pharmacy benefit management services marketed under the
name Catalyst Rx include: claims processing, benefit design consultation, drug
utilization review, formulary management, drug data analysis services and mail
order services. Additionally, the Company operates a national retail pharmacy
network with over 58,000 participating pharmacies.

    About SXC Health Solutions
    SXC Health Solutions, Inc. (SXC) is a leading provider of pharmacy
benefits management (PBM) services and healthcare IT solutions to the
healthcare benefits management industry. The Company's product offerings and
solutions combine a wide range of software applications, application service
provider (ASP) processing services and professional services, designed for
many of the largest organizations in the pharmaceutical supply chain, such as
Federal, provincial, and, state and local governments, pharmacy benefit
managers, managed care organizations, retail pharmacy chains and other
healthcare intermediaries. SXC is based in Lombard, Illinois with locations
in; Scottsdale, Arizona; Warminster, Pennsylvania; Milton, Ontario and
Victoria, British Columbia. For more information please visit www.sxc.com.

    Forward-Looking Statements
    Certain statements included herein, including those that express
management's expectations or estimates of our future performance, constitute
"forward-looking statements" within the meaning of applicable securities laws.
Forward-looking statements are necessarily based upon a number of estimates
and assumptions that, while considered reasonable by management at this time,
are inherently subject to significant business, economic and competitive
uncertainties and contingencies. We caution that such forward-looking
statements involve known and unknown risks, uncertainties and other risks that
may cause our actual financial results, performance, or achievements to be
materially different from our estimated future results, performance or
achievements expressed or implied by those forward-looking statements.
Numerous factors could cause actual results to differ materially from those in
the forward-looking statements, including without limitation, our ability to
achieve increased market acceptance for our product offerings and penetrate
new markets; consolidation in the healthcare industry; the existence of
undetected errors or similar problems in our software products; our ability to
identify and complete acquisitions, manage our growth and integrate
acquisitions; our ability to compete successfully; potential liability for the
use of incorrect or incomplete data; the length of the sales cycle for our
healthcare software solutions; interruption of our operations due to outside
sources; our dependence on key customers; maintaining our intellectual
property rights and litigation involving intellectual property rights; our
ability to obtain, use or successfully integrate third-party licensed
technology; compliance with existing laws, regulations and industry
initiatives and future change in laws or regulations in the healthcare
industry; breach of our security by third parties; our dependence on the
expertise of our key personnel; our access to sufficient capital to fund our
future requirements; and potential write-offs of goodwill or other intangible
assets. This list is not exhaustive of the factors that may affect any of our
forward-looking statements. Investors are cautioned not to put undue reliance
on forward-looking statements. All subsequent written and oral forward-looking
statements attributable to SXC or persons acting on our behalf are expressly
qualified in their entirety by this notice. We disclaim any intent or
obligation to update publicly these forward-looking statements, whether as a
result of new information, future events or otherwise. Risks and uncertainties
about our business are more fully discussed in our Annual Information Form.
    Certain of the assumptions made in preparing forward-looking information
and management's expectations include: maintenance of our existing customers
and contracts, our ability to market our products successfully to anticipated
customers, the impact of increasing competition, the growth of prescription
drug utilization rates at predicted levels, the retention of our key
personnel, our customers continuing to process transactions at historical
levels, that our systems will not be interrupted for any significant period of
time, that our products will perform free of major errors, our ability to
obtain financing on acceptable terms and that there will be no significant
changes in the regulation of our business.

    %SEDAR: 00001439E




For further information:

For further information: Jeff Park, Chief Financial Officer, Systems
Xcellence Inc., Tel: (630) 577-3206, investors@sxc.com; Dave Mason, Investor
Relations, The Equicom Group Inc., (416) 815-0700 ext. 237,
dmason@equicomgroup.com; Susan Noonan, Investor Relations - U.S., The SAN
Group, LLC, (212) 966-3650, susan@sanoonan.com; Judith Sylk-Siegel, Media
Contact, Rx Communications Group, (917) 322-2164, jsylksiegel@rxir.com

Organization Profile

SYSTEMS XCELLENCE INC.

More on this organization

Catamaran

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890